ActiveGRANT

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This DoD funding supports high-risk, hypothesis-driven research to discover new ALS drugs and therapies. Applications emphasizing novel approaches can succeed without preliminary data, enabling bold therapeutic innovation.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 4, 2026
Due Date
September 30, 2026

Official Description

<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.</p><p><br></p><p><strong>Distinctive Features: </strong>Potential impact...
View on official source

Change History

Opportunity AddedMay 4, 2026 at 2:56 PM

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

New Grants.gov opportunity: DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial